Papadakos, S.P.; Argyrou, A.; Lekakis, V.; Arvanitakis, K.; Kalisperati, P.; Stergiou, I.E.; Konstantinidis, I.; Schizas, D.; Koufakis, T.; Germanidis, G.;
et al. Metformin in Esophageal Carcinoma: Exploring Molecular Mechanisms and Therapeutic Insights. Int. J. Mol. Sci. 2024, 25, 2978.
https://doi.org/10.3390/ijms25052978
AMA Style
Papadakos SP, Argyrou A, Lekakis V, Arvanitakis K, Kalisperati P, Stergiou IE, Konstantinidis I, Schizas D, Koufakis T, Germanidis G,
et al. Metformin in Esophageal Carcinoma: Exploring Molecular Mechanisms and Therapeutic Insights. International Journal of Molecular Sciences. 2024; 25(5):2978.
https://doi.org/10.3390/ijms25052978
Chicago/Turabian Style
Papadakos, Stavros P., Alexandra Argyrou, Vasileios Lekakis, Konstantinos Arvanitakis, Polyxeni Kalisperati, Ioanna E. Stergiou, Ippokratis Konstantinidis, Dimitrios Schizas, Theocharis Koufakis, Georgios Germanidis,
and et al. 2024. "Metformin in Esophageal Carcinoma: Exploring Molecular Mechanisms and Therapeutic Insights" International Journal of Molecular Sciences 25, no. 5: 2978.
https://doi.org/10.3390/ijms25052978
APA Style
Papadakos, S. P., Argyrou, A., Lekakis, V., Arvanitakis, K., Kalisperati, P., Stergiou, I. E., Konstantinidis, I., Schizas, D., Koufakis, T., Germanidis, G., & Theocharis, S.
(2024). Metformin in Esophageal Carcinoma: Exploring Molecular Mechanisms and Therapeutic Insights. International Journal of Molecular Sciences, 25(5), 2978.
https://doi.org/10.3390/ijms25052978